slides · global inventory
Resolution
Beat collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 42,534
Current window 30,511-30,540
Pages 1,418
Rows per page 30
Beat
30,511-30,540 of 42,534
30
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
31
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
32
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
33
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
34
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
35
The slide uses a comparative diagram to illustrate the selective mechanism of action.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
36
The slide uses a ribbon-style process diagram to represent sequential or cumulative progress.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
37
The slide uses a quote from a key advisor to validate the scientific potential of the company's technology beyond its primary cancer focus.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
38
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
39
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
40
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
41
The slide uses a horizontal arrow-based timeline structure to map specific drug candidates to their upcoming regulatory and clinical milestones.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
10
The slide uses a process flow framework to explain revenue recognition and cash collection timing.Eos Energy | Results Presentation Deck | 13 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · ActionLoop · Quick Win Big Bet1 hit
11
Eos Energy | Results Presentation Deck | 13 slidesEos Energy | Results Presentation Deck | 13 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · ActionLoop · Quick Win Big Bet1 hit
12
The slide uses a waterfall-style comparison for Revenue and COGS to emphasize year-over-year changes.Eos Energy | Results Presentation Deck | 13 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · ActionLoop · Quick Win Big Bet1 hit
13
The slide uses a structured list format to present three distinct performance categories.Eos Energy | Results Presentation Deck | 13 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Action1 hit
06
The diagram illustrates a biological signaling pathway with specific nodes highlighted as targets for the company's therapeutic approach.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
07
The slide uses a Gantt-style visualization for clinical trial stages.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
08
The slide uses a biological process diagram to map drug assets to specific protein targets.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
09
The slide uses a matrix structure to map indications to benchmarks, specific drug regimens, and trial names, with a footer detailing active clinical trial collaboration and supply agreements (CTCSAs).Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
10
The chart uses a stacked bar approach to represent US and European patient counts per clinical program.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
11
The slide combines a biological pathway diagram (left) with a quantitative market sizing table (right).Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
12
The kinome tree visualization (KINOMEscan) is a standard industry tool for demonstrating kinase selectivity.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
13
The slide combines a biological pathway diagram (mechanism of action) with a clinical trial summary table.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
14
Includes two waterfall plots comparing patient responses; source cited as Novartis materials.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
42
The slide uses a table format to communicate a product development roadmap.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Impact & Next StepsLoop · Quick Win Big Bet1 hit
43
Erasca | Investor Presentation Deck | 56 slidesErasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Impact & Next StepsLoop · Quick Win Big Bet1 hit
44
Features the Lorenz attractor graphic, which is a signature visual for Erasca.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Impact & Next StepsLoop · Quick Win Big Bet1 hit
16
Etsy | Results Presentation Deck | 42 slidesEtsy | Results Presentation Deck | 42 slides · Etsy
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
17
Etsy | Results Presentation Deck | 42 slidesEtsy | Results Presentation Deck | 42 slides · Etsy
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit